Search All News
Cholesterol-lowering drugs called statins have the potential to reduce heart disease in people with obstructive sleep apnea regardless of CPAP use, suggests a new study from Columbia University.
After a sudden medical scare, many people develop a fear of health care and are afraid to adopt new health habits. The Center for Fearless Behavior Change is testing ways to help.
Iok In Christine Chio, PhD, and Oliver Clarke, PhD, early-career investigators at VP&S, are 2023 recipients of prestigious awards from the Irma T. Hirschl Trust Research Scientist Program.
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
- September 3, 2021
New proposed test values for iron deficiency could double the number of women and triple the number of children detected with the condition.
- August 30, 2021
Researchers at Columbia University Vagelos College of Physicians and Surgeons are leading the first U.S. trial of an experimental vaccine designed to treat an opioid use disorder.
- August 16, 2021
A new preclinical study provides the first direct evidence that loss of a placental hormone during pregnancy alters long-term brain development, causing autism-like behaviors in male offspring.
- August 4, 2021
Keith Diaz, May Hua, Jennifer Woo Baidal, and Hanrui Zhang will receive funding over the next three years to support their clinical and translational research.
- August 3, 2021
A fat ‘shield’ that protects natural killer cells from self-destruction also allows some cancer cells to evade destruction by the immune system, researchers at Columbia University have found.
- August 2, 2021
A new clinical trial at Columbia could help determine if a hypertension drug can prevent osteoporosis in postmenopausal women.
- August 2, 2021
A new podcast explores explores breakthrough innovations being developed in Columbia’s scientific laboratories.
- July 7, 2021
Twelve Columbia research teams have been awarded Columbia Life Science Accelerator pilot grants to develop technologies that aim to change the way patients are treated or diagnosed.
- July 1, 2021
Even a brief exposure to addictive medications for surgery-related pain or anxiety can lead to long-term use, a study by Columbia researchers has found.
- June 22, 2021
A new study from researchers at Columbia University is the first to quantitatively link psychological stress to graying hair in people and find that the process is reversible.